TW432064B - Bicyclic compounds and relevant pharmaceutical compositions for the treatment of stress-related diseases - Google Patents
Bicyclic compounds and relevant pharmaceutical compositions for the treatment of stress-related diseases Download PDFInfo
- Publication number
- TW432064B TW432064B TW084105306A TW84105306A TW432064B TW 432064 B TW432064 B TW 432064B TW 084105306 A TW084105306 A TW 084105306A TW 84105306 A TW84105306 A TW 84105306A TW 432064 B TW432064 B TW 432064B
- Authority
- TW
- Taiwan
- Prior art keywords
- image
- projection
- unit
- day
- output
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 125000002619 bicyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000003627 8 membered carbocyclic group Chemical group 0.000 abstract 1
- 125000005330 8 membered heterocyclic group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002346 iodo group Chemical group I* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical compound CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- -1 tetrahydrofuran-3-yloxy Chemical group 0.000 abstract 1
- 230000005540 biological transmission Effects 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 238000010586 diagram Methods 0.000 description 8
- 230000002452 interceptive effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000009434 installation Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Controls And Circuits For Display Device (AREA)
- Projection Apparatus (AREA)
Description
五、新型說明: 【新型所屬之技術領域】 本創^關於影像輪出系統,特別係—種透過影像 置。、及其衫像輪出控制單元之投影應用裝 【先前技術】 外用之攝影裂置(數位攝影機或數位相機)於摘取 或靜態影像後,進行影音數位化之處理及轉換, 、’儲存於攝f彡裝㈣所建置之記憶體巾 影褒置上所設置之㈣mm 乍者了透過攝 罾一妙 (‘,、'貝不螢幕進仃動態晝面或靜態影像之預 右將所擷取m料進行外部簡報投影放映時, 裝置中之動態晝面或靜態影像傳輸 之驅動以及編輯程式進行轉樓以及相關之處理。透過= 所連接之數位投影機展放㈣晝面或靜態影像。 =由於近年來’於大眾會議場合進行投影簡報時, 必須攜帶仙電腦以及數位投影機等硬體設備,並配合摄 影裝置所#|取後之影音㈣進行外部投影呈現。不僅^ 先行於電腦中進行影音㈣之編輯與儲存,且必須攜帶數 位投影所需之各種硬體設備。數位資料傳輸轉檔之過程户 理繁稷’且過多及繁重之硬體設備更造成使用者攜帶時的 因擾與不便。此外,傳統的數位投影機僅僅與電腦結 用過於單調且單一無變化。 Μ 因此,基於上面所述之缺點,是以本創作提出一種應 M432064 =::r過手持觸控式無線影像輪出裝置… 内容】及啟用特殊之多功一 本創作之目的在於提供一種用於 發之應用模組,其可葬由一丰姓6 、办裝置或功能所開 之應用平台作下载連^及w控式無線影像輸出裝置 本創作提特殊之多功能投影輪出。 *控制單元:投影瘅:輸出裝置及其影像輸 ►料卢搜…"應用裝置,而影像輸出裝置包含一 :理早兀,一影像輸出單元,耦接微處理單 出-影像資料;一影像輸出 用以輸 以控制投影裝置輸出之_投影畫面,二=單元, 匕括才曰疋μ,用以指定影像 : 影像輸出裝置;以及一顯示單元,輕接微處理=褒置或 其中影像輪出控制單元更包括一特定 啟-特定晝面’特定畫面包括鍵盤畫面=二 士:面功能晝面;-晝面分享單元,用於分享投丄 旦:控制早7G,用以控制投影晝面;以及一手勢與 :啟皁元’用以開啟手勢與指向投影晝面,並操控投二 影像傳輸與接收開啟單元,開啟影像即時傳料ς ,以利於即時或同步將影像投影輸出。 根據本創作之另一觀點’提供一種投 輪出裝置之系統。 直、口。衫像 【實施方式】 本創作將配合其較佳實施例與隨附之圖示詳述於下。 WJ2064 應可理解者為本創作中所有之較佳實施例僅為例示之用, 並非用以限制。因此除文中之較佳實施例外,本創作亦可 廣泛地應用在其他實施例中。且本創作並不受限於 施例,應以隨附之申缚直士丨e m “ Ά 了又甲。月寻利乾圍及其同等領域而定。 $ Λ創作提供一種透過影像輸出裝置及其影像輸 出控制早%之投影應用裝置。影音輸出裝置電 投影裝置以進行影像投影。影音輸出裝置包含一 ^
=單元,電性連接投影裝置之微處理單元。此外,J 置進行充電。 又办衷置以及衫音輸出裴 像』:根據本創作之一實施例之投影裝置與影 像輸出裝置、行動電話、上〇〇可以為觸控式無線影 人數位助理㈣A)、筆 同"遊戲機、個 裝置。在本實施例中,影==腦等可攜式電子 控制單元104,投## w , ’ 、 100包括一影像輸出 才又衫裝置102包括一料卢神苗_ 影模組⑽。影像輸出控 ^理早⑦咖與投 微處理單元106耦接 耦接微處理單元106, 控制單元1 04係透過—介 5,影像輸出 理單元服為—微處以處理單元⑽。微處 制單元】04之指令輸出至該微利用影像輪出控 單元】06處理從影像轸 ^早兀106,並依微處理 代办像翰出裝置1〇〇輪 過投影模•⑽投影輪出影像投 二像二:,而透 ~囬U2。輸出影像晝 :放大倍率端視實際的應用或需 之’利用影像輸出控制單元104之沪入7 *正換。 制影像書面的^ 直接或間接控 輪出穿置二! 例中,投影裝置102與影像 輪出ί之連結(或溝通)110方式,包括底下三種:a) 插入影像之連接口(介面)直接 透過各自果置b).無線傳輸方式連接, 接。舉内 線模組作連接〇·使用連接線連 特丄 ,影像輸出裝置100可以透過下載- 以透^右軟體以作為影像輸出控制單元1〇4。下載方式可 下载。舉=,、無線傳輸或儲存媒體(光碟或隨身碟)來 一無“用商” ί創作之影像輸出控制單元104可以從 儲存於影像輸出裝置⑽之中。因此 使用者=控制早70104可以為下載之應用軟體。當 同時此ί線C而儲存在無線影音輸出裝置_, !叫':: 裝1 1〇0實體連結至行動投影裝置 二影裝置— 嚷』具所5又计之特殊投影畫面結果。 單元之一實施例之影像輸出㈣ 單元200、調整單元二出:二單元1〇4包括影像旋轉控制 元230、畫面分享 曰疋早几220、特定晝面開啟單 與接收開啟單元2Γ〇畫面控制單元㈣、影像傳輸 旋轉控制單元200可以及手勢與指向開啟單元270。影像 °以控制投射影像之旋轉方向與角度, 例如可作90、180、270 針)旋轉。調整單元2ΪΠ 又之正 '反向(順時針、逆時 或播放音量0可調整投射影像之對比度與亮度, 例如可以指定或決定晝面輸出至那-裝置。 y輪出端(影像輸出裝置100)中之苹 可以透過指定單亓”Λ 1 之某(第一)晝面 102),另一(第 而1向輸出至投影端(投影裝置 的營幕上。換向輸出至影像輸出裝置刚本身 像輪出裳置m之心:m之投影晝面可與影 〇α _ * 旦面不一致。使用者可以诱禍扣— ^ 22。隨意指畫面所要輸出的裝置二 出,輸出端或投齡上述之指向得以在投 程中即時或同步進行。特定晝面開啟單元230可 面:舉二:㈣:,如鍵盤畫面及/或類滑鼠介面功能畫 定晝面開啟輩矛Λ从 在開啟特 〇之後’手持觸控式無線影像輸出裝置 1〇〇…示榮幕將出現鍵盤畫面及類滑鼠介面功能晝 面’以供使用者觸控該鍵盤晝面及類滑鼠介面功能畫面作 為打字輸入及游標控制之介面,而將投影端當作欲輸入或 控制畫面的顯示螢幕。上述即為第二台螢幕概念的應用。 晝面分享單元240可以分享畫面。多個影像輸出裝置 100可以透過晝面分享單元240互相分享同一晝面,即時 或同步將此晝面於投影裝置102端投影輸出。舉一實施例 而言,當某乙台(第一)無線影像輸出裝置(主機)100,例如 智慧型手機,連接行動投影裝置102,並啟動影像輸出控 M432064 制單疋104所内建之一互動遊戲或者一網路遊戲作為影像 投影時,可以透過一無線收發模組(例如RF模組或藍芽模 組)與同樣具有動影像輸出控制單元1〇4之另一乙台(第二) 智慧型手機(副機)作雙打。基於晝面分享單元24〇,乙台智 慧型手機即可同步取得訊號,並出現控制游標或操控介面 於螢幕上以加入互動遊戲或網路遊戲中。雙方之互動遊戲 或網路遊戲畫面同步與即時(real time)於行動投影裝置 102中投影輸出,並可將遊戲結果記錄在主機!⑼中。在 另一實施例中,網路遊戲中的畫面可以經由有線傳輸方式 即時呈現,例如呈現於一平板電腦中。利用畫面分享單元 240可以使得多個影像輸μ置進行互動遊戲。 畫面控制單元250可以控制投影晝面。當某 觸控式無線裝置(主機)100連接行動投影裝置1〇2,寺 影像輸出控制單元1G4而作影像投影時 2 ::,之另-乙台無線裝置_二= 投影晝面之指向及顯示。利用畫面控二控制該 第-…輪出裝置作投影畫面指向以及遙控。 於盘Γ象傳輸與接收開啟單元260係用以開啟影像即時僂 =第:或同步將影像投影輸出。舉-實:= : 第),,,、線影像輸出裝置100,例如知㈣丰嬙由 T行動投影裂置⑽,並啟動影像輸出";單:機’連 像投影時,撥打 Μ控制早70 104作影 方(第二η'慧型:::具= 乙方冋步啟動影像輸出控制單元 M4J2U04 =收電話時,可將對方回應電話之即 :建之自,攝影鏡頭在甲方端作同步投影。若乙方= 作裝置則f方之自拍之即時影像亦可在乙方端 :乂投影。利用影像傳輸與接收開啟單元26〇可以達 成視訊螢幕之功能與應用。 手勢與指㈣啟單元27G可以開啟手勢 :偵測’並操控行動投影裝請輸出之投影書面。:: 貝施例而言,攝影鏡頭15G(如第五圖所㈤可以内建餘 觸控式無線影像輸出裝置1〇〇中,透過並 7 取像韓於(站在)投影端者之手勢與其指向之座^ 透過運异並同步操控顯示影像。 所述之目的’本創作之無線影像輸出裝置 匕3力^速度感應器、-手勢辨識模組。加速度感 ::::生連接微處理單元’以用於輸出加速度感應器之二 =^曰向資料至微處理單元。手勢辨識模組電性連接微 i t二理及比對經由微處理單元轉送而來 、、又H之手勢與其指向信號。記憶體内儲 :庫,而資料庫中儲存了複數種手勢與其指向之原始資 利用手勢辨識桓組比較儲存於資料^ ^ ^ ^ ^ ;其指向之原始資料,得以解析當前手勢與其指向之= 或訊號。 上述影像旋轉控制單元2〇〇、調整單%21〇、指定單元 =、特定晝面開啟單m晝面分享單元240、晝面控 •早兀250、景;像傳輸與接收開啟單元以及手勢與指 M432064 、啟單元270輕接微處理單元i〇6與微處理單元η〗, 這些功能性單柄輸出至行動投影裝置⑽之微處理晶片 以控制投影影像或畫面之輸出。上述單元可以透過指 令、軟體或程式來執行。 处广合上述,影像輸出控制單元1〇4至少具有底下之功 2. 3. 4. 5. 6. 控制投射影像之旋轉方向與角度; =投影影像之對比度、亮纟或播放音量,· 扣定影像資料、晝面輸出至那一裝置; 開啟鍵盤畫面及/或類滑鼠介面功能晝面; 分享畫面’即時或同步將晝面投影輸出; 控制投影晝面; 象即時傳輸與接收,即時或同步將影像 夺又影輪出; 8. 開啟手勢與指向投影晝面偵測。 第二圖顯示為根據本 影像輸出裝置之功炉方檢同 實細例之投影裝置與 刀月b方塊圖。在太眚始μ 士 與影像輸出穿 任本只細例中,投影裝置 供電。影像輸出^ #为別透過電池〗2〇與電池126以 电办像輸出裝置1〇〇 — 憶體128、一鞀+ 〇口_ ^處理早兀132、一記 體128、顯示軍元影音輸出單元136。記憶 理單元⑴。影像輪出裝單元136分軸接微處 出單元130以輪出旦 了以透過其本身的影音輸 询出衫像晝面於顯 128可以用以儲存 〃 μ早兀134上。記憶體 貝科’例如影立次女丨 办日貝#。投影裝置1〇2可 M432064 地包括記憶體124用以儲存資料。記憶體124 祸接微處理單元1〇6。 在:實施例中,顯示單元134包括液晶顯示器(lcd)。 U4可以顯示影像畫面、游標、操控介面、鍵 盜旦面及/或類滑鼠介面功能畫面於螢幕上。 在另:實施例中,投影裝置1〇2 t包括一充電模組 ^士’如弟四圖所示。投影裝置1〇2本身可與外部電源13〇 此投影裝置1〇2進行供電或充電 1。2:=120與電池126。在此實施例中,投影裝置 將充曰電模組122整合於其中’利用外部電源13〇之供 投影^ 裝f 1〇2成為具有電源供應功能的行動 #置100二之’―但投影裝置102電性連接影音輸出 々褒置102進行電源供應或充電。 ^另^施例中,影音輸出裝置1〇〇更包括一無線模 ⑷,如第150;投影裝置102⑽ 她。k 。影音輸出襄置⑽例如為智慧型手 …線模、组140與141為一無線收發 :=組。利用無線模組14〇與141,無線二 N接Μ2之間可以進行無線訊號或資料之傳 ^ t J以進仃無線訊號或資料夕席 :另、接:。攝影鏡㊣15。用以掏取外界物 專 在另一實施例中,影音輪出震置刚更包括一網=模: 142 ’如第六圖所示。在本實 例如為平板電月《< :, 例中’影音輸出裝置100 勹卞板電知,利用網路模組142,- 罝100 之間可以進行有績3 h 一個影像輸出裝置 , 有線矾唬或貧料之傳輸與接收。β 1 才吴組142,影僮私山莊_ 按收透過網路 . . '、 出裝置100可以即時瀏覽網路下# 透過投景彡裝1 1G2 «彳 之-像畫面投射輪出。在另—方面 J二所劍覽 :以將儲存於記憶體中的資料輸出,並_ 震置_之顯示單元134或透過投影茫置1:於, 此外,也可以同技敖人 置1〇2投影輸出。 影像輪出裝置1〇〇由μ …周路模組142於 .士 100中,如弟七圖所示。上述這歧眚 ’充電模組122係選擇性地, 也歹’ 上貝域技藝者,本創作雖以較佳實例閣明如 精神:範Γ=限定本創作之精神。在不脫離本 之申H作之修改與類似的配置,均應包含在下述 構,二傲^内’此範圍應覆蓋所有類似修改與類似結 且應做最寬廣的詮釋。 【圖式簡單說明】 輪出^圖顯示根據本創作之一實施例之投影裝置與影像 輸出裂置之功能方塊圖。 .第一圖顯示根據本創作之一實施例之影像輸出控制單 凡之功能方塊圖。 早 第二圖顯不根據本創作之一實施例之投影裝置盥影像 輸出裝置之功能方塊圖。 /、 第四圖顯示根據本創作之一實施例之投影裝置與影像 12 輪出裝置之功能方塊圖。 第五圖顯示根據本創 輪出装置之魏方塊圖。實施例之投影裝置與影像 實施例之投影裝置與影像 實施例之投影裴置與影像 第六圖顯示根據本創作 〜出襄置之功能方塊圖。 第七圖顯示根據本創作之 輪出裝置之功能方塊圖。 【主要元件符號說明】 影像輸出裝置100 投影裝置102 影像輸出控制單元1〇4 微處理單元1〇6、132 投影模組108 連結110 投影晝面112 電池 120、126 充電模組122 記憶體124、128 外部電源130 顯示單元134 影音輸出單元136 無線模組140、141 網路模組142 攝影鏡頭150 13 M432064 影像旋轉控制單元200 調整單元210 指定單元220 特定晝面開啟單元230 畫面分享單元240 畫面控制單元250 影像傳輸與接收開啟單元260 手勢與指向開啟單元270
14 M432064 , video output control unit includes a directing unit for directing the video data to the projection device or the video output device. 四、指定代表圖: (一)本案指定代表圖為:第(一)圖。 (一)本代表圖之元件符號簡單說明: 影像輸出裝置100 投影裝置102 影像輪出控制單元104 微處理單元106 投影模組1〇8 連結110 投影晝面112
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26005594A | 1994-06-16 | 1994-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW432064B true TW432064B (en) | 2001-05-01 |
Family
ID=22987613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW084105306A TW432064B (en) | 1994-06-16 | 1995-05-25 | Bicyclic compounds and relevant pharmaceutical compositions for the treatment of stress-related diseases |
Country Status (27)
Country | Link |
---|---|
US (1) | US6248753B1 (zh) |
EP (1) | EP0765327B1 (zh) |
JP (1) | JP2891544B2 (zh) |
KR (1) | KR100235277B1 (zh) |
CN (1) | CN1056611C (zh) |
AT (1) | ATE182332T1 (zh) |
AU (1) | AU687196B2 (zh) |
BR (1) | BR9502707A (zh) |
CA (1) | CA2192820C (zh) |
CO (1) | CO4290424A1 (zh) |
CZ (1) | CZ287613B6 (zh) |
DE (1) | DE69510940T2 (zh) |
DK (1) | DK0765327T3 (zh) |
ES (1) | ES2135062T3 (zh) |
FI (1) | FI112659B (zh) |
GR (1) | GR3031166T3 (zh) |
HU (1) | HU219911B (zh) |
IL (1) | IL114003A (zh) |
MX (1) | MX9606504A (zh) |
NO (1) | NO307968B1 (zh) |
NZ (1) | NZ284846A (zh) |
PE (1) | PE13396A1 (zh) |
PL (1) | PL181895B1 (zh) |
RU (1) | RU2135498C1 (zh) |
TW (1) | TW432064B (zh) |
WO (1) | WO1995034563A1 (zh) |
ZA (1) | ZA954679B (zh) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
US7125880B1 (en) | 1995-06-06 | 2006-10-24 | Pfizer Inc. | Corticotropin releasing factor antagonists |
AU738304B2 (en) * | 1995-10-13 | 2001-09-13 | Neurogen Corporation | Certain pyrrolopyridine derivatives; novel CRF 1 specific ligands |
US6992188B1 (en) | 1995-12-08 | 2006-01-31 | Pfizer, Inc. | Substituted heterocyclic derivatives |
CA2249598A1 (en) * | 1996-03-26 | 1997-10-02 | Paul Joseph Gilligan | Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives |
ZA971896B (en) | 1996-03-26 | 1998-09-07 | Du Pont Merck Pharma | Aryloxy-and arythio-fused pyridines and pyrimidines and derivatives |
US6107300A (en) * | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
ZA972497B (en) | 1996-03-27 | 1998-09-25 | Du Pont Merck Pharma | Arylamino fused pyridines and pyrimidines |
ZA973884B (en) | 1996-05-23 | 1998-11-06 | Du Pont Merck Pharma | Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
US7094782B1 (en) | 1996-07-24 | 2006-08-22 | Bristol-Myers Squibb Company | Azolo triazines and pyrimidines |
US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
CZ292806B6 (cs) * | 1996-08-06 | 2003-12-17 | Pfizer Inc. | Pyrido- nebo pyrimido-6,6- nebo -6,7-bicyklické deriváty, farmaceutické kompozice na jejich bázi |
TW477787B (en) * | 1996-08-27 | 2002-03-01 | Pfizer | Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same |
JP2001502300A (ja) | 1996-09-16 | 2001-02-20 | デュポン ファーマシューティカルズ カンパニー | ピラジノン類およびトリアジノン類およびその誘導体類 |
JP2001511813A (ja) * | 1997-02-18 | 2001-08-14 | ニューロクライン バイオサイエンシーズ,インコーポレイテッド | Crfレセプターアンタゴニストおよびそれらに関連する方法 |
AU746706B2 (en) * | 1997-07-03 | 2002-05-02 | Du Pont Pharmaceuticals Company | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
DE69807085D1 (de) | 1997-09-02 | 2002-09-12 | Bristol Myers Squibb Pharma Co | Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress |
NL1010018C2 (nl) * | 1997-09-09 | 1999-03-10 | Duphar Int Res | Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking. |
US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
US6472402B1 (en) | 1998-04-02 | 2002-10-29 | Neurogen Corporation | Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives |
AU3378799A (en) | 1998-04-02 | 1999-10-25 | Neurogen Corporation | Aminoalkyl substituted pyrrolo(2,3-b)pyridine and pyrrolo(2,3-d)pyrimidine derivatives: modulators of crf1 receptors |
CA2326319A1 (en) | 1998-04-02 | 1999-10-14 | Neurogen Corporation | Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands |
US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
DE19837387A1 (de) * | 1998-08-18 | 2000-02-24 | Aventis Res & Tech Gmbh & Co | 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung |
US6174912B1 (en) | 1998-08-21 | 2001-01-16 | Dupont Pharmaceuticals Company | Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonists |
ES2180338T3 (es) | 1998-11-12 | 2003-02-01 | Neurocrine Biosciences Inc | Antagonistas del receptor de crf y metodos relacionados. |
JP2002529469A (ja) | 1998-11-12 | 2002-09-10 | ニューロクライン バイオサイエンシーズ, インコーポレイテッド | Crfレセプターアンタゴニストおよびそれに関する方法 |
US6531475B1 (en) | 1998-11-12 | 2003-03-11 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
US6271380B1 (en) | 1998-12-30 | 2001-08-07 | Dupont Pharmaceuticals Company | 1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands |
EP1040831A3 (en) | 1999-04-02 | 2003-05-02 | Pfizer Products Inc. | Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death |
US6387894B1 (en) | 1999-06-11 | 2002-05-14 | Pfizer Inc. | Use of CRF antagonists and renin-angiotensin system inhibitors |
US6432989B1 (en) * | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
CZ20021086A3 (cs) | 1999-09-30 | 2002-10-16 | Neurogen Corporation | Alkylendiaminem substituované heterocykly |
IL139197A0 (en) | 1999-10-29 | 2001-11-25 | Pfizer Prod Inc | Use of corticotropin releasing factor antagonists and related compositions |
TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
EP1244666A1 (en) * | 1999-12-17 | 2002-10-02 | Bristol-Myers Squibb Pharma Company | Imidazopyrimidinyl and imidazopyridinyl derivatives |
AU2001232271A1 (en) * | 2000-02-14 | 2001-08-20 | Japan Tobacco Inc. | Preventives/remedies for postoperative stress |
AU2001253540A1 (en) | 2000-04-25 | 2001-11-07 | Bristol-Myers Squibb Company | Use of 5-thio-, sulfinyl- and sulfonylpyrazolo(3,4-b)-pyridines as cyclin dependent kinase inhibitors |
US6630476B2 (en) * | 2000-07-07 | 2003-10-07 | Bristol-Myers Squibb Pharma Company | Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists |
PE20020394A1 (es) | 2000-08-18 | 2002-06-21 | Agouron Pharma | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 |
DE10042093A1 (de) * | 2000-08-26 | 2002-03-07 | Dresden Arzneimittel | Antikonvulsiv wirkende 6,7-Dihydro-pyrrolo[3,4-d]pyridin-5-one und Verfahren zu deren Darstellung |
WO2002024703A1 (en) | 2000-09-22 | 2002-03-28 | Akzo Nobel N.V. | Bicyclic heteroaromatic compounds |
TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
DE10110747A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
JP4206273B2 (ja) | 2001-04-27 | 2009-01-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾロ[1,5−a]ピリジン化合物およびその医薬 |
GB0117396D0 (en) | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
GB0128287D0 (en) * | 2001-11-26 | 2002-01-16 | Smithkline Beecham Plc | Novel method and compounds |
CN1326855C (zh) * | 2001-12-04 | 2007-07-18 | 弗·哈夫曼-拉罗切有限公司 | 稠环吡唑衍生物 |
US7291630B2 (en) * | 2002-03-28 | 2007-11-06 | Eisai Co., Ltd. | Azaindoles as inhibitors of c-Jun N-terminal kinases |
GB0230045D0 (en) * | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
KR100984085B1 (ko) | 2002-10-22 | 2010-09-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 7-페닐 피라졸로피리딘 화합물 |
TWI270549B (en) | 2002-12-26 | 2007-01-11 | Taisho Pharmaceutical Co Ltd | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
GB0308208D0 (en) | 2003-04-09 | 2003-05-14 | Glaxo Group Ltd | Chemical compounds |
MY144903A (en) | 2004-06-17 | 2011-11-30 | Novartis Ag | Pyrrolopyridine derivatives and their use as crth2 antagonists |
DE102004042607A1 (de) | 2004-09-03 | 2006-03-09 | Bayer Healthcare Ag | Substituierte Phenylaminothiazole und ihre Verwendung |
DE602005014375D1 (de) * | 2004-10-19 | 2009-06-18 | Neurocrine Biosciences Inc | Crf-rezeptor-antagonisten und zugehörige verfahren |
WO2007031838A1 (en) | 2005-09-16 | 2007-03-22 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
GB0525143D0 (en) * | 2005-12-09 | 2006-01-18 | Novartis Ag | Organic compounds |
GB0525337D0 (en) * | 2005-12-13 | 2006-01-18 | Novartis Ag | Organic compounds |
MX2008011220A (es) * | 2006-03-07 | 2008-09-11 | Array Biopharma Inc | Compuestos de pirazol heterobiciclicos y metodos de uso. |
CN101460497A (zh) * | 2006-04-04 | 2009-06-17 | 菲布罗根有限公司 | 作为hif调节剂的吡咯并吡啶和噻唑并吡啶化合物 |
TW200815349A (en) | 2006-06-22 | 2008-04-01 | Astrazeneca Ab | New compounds |
DE102006042143A1 (de) | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
DE102006056740A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
DE102006056739A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
DE102007035367A1 (de) | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
DE102007061763A1 (de) | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
DE102007061764A1 (de) | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
DE102008013587A1 (de) | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
KR101601994B1 (ko) | 2008-04-15 | 2016-03-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 3-페닐피라졸로[5,1-b]티아졸 화합물 |
US8791146B2 (en) | 2008-05-29 | 2014-07-29 | Bayer Intellectual Property Gmbh | 2-alkoxy-substituted dicyanopyridines and their use |
TW201020244A (en) | 2008-11-14 | 2010-06-01 | Astrazeneca Ab | New compounds |
DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
DE102009006602A1 (de) | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
US20120058983A1 (en) | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
CA2836463A1 (en) | 2011-05-17 | 2012-11-22 | Discoverybiomed Inc. | Treating protein folding disorders with small molecule cftr correctors |
WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
US9546176B2 (en) | 2012-11-20 | 2017-01-17 | Discoverybiomed, Inc. | Small molecule bicyclic and tricyclic CFTR correctors |
AU2013348018A1 (en) | 2012-11-20 | 2015-06-04 | Discoverybiomed, Inc. | Small molecule CFTR correctors |
TWI498325B (zh) | 2013-01-18 | 2015-09-01 | Hoffmann La Roche | 3-取代吡唑及其用途 |
CN108558876B (zh) * | 2018-05-28 | 2020-08-04 | 中南大学 | 吡唑[3,4-b]并吡啶类衍生物及其制备方法和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3925388A (en) * | 1971-08-05 | 1975-12-09 | Squibb & Sons Inc | 4-Piperazino-{8 3,4-b{9 pyridine-5-carboxylic acids and esters |
US3804843A (en) * | 1971-12-23 | 1974-04-16 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine carbonitriles |
DE3145287A1 (de) | 1981-11-14 | 1983-05-19 | Troponwerke GmbH & Co KG, 5000 Köln | Pyrrolo (2.3-d)pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
IT1154024B (it) * | 1982-09-22 | 1987-01-21 | Lepetit Spa | Derivati pridinici e procedimento per la loro produzione |
US4605642A (en) | 1984-02-23 | 1986-08-12 | The Salk Institute For Biological Studies | CRF antagonists |
US5063245A (en) | 1990-03-28 | 1991-11-05 | Nova Pharmaceutical Corporation | Corticotropin-releasing factor antagonism compounds |
JPH05196008A (ja) | 1991-11-20 | 1993-08-06 | Myotoku Kk | 空気圧動作装置とその制御装置 |
IT222061Z2 (it) | 1991-12-03 | 1994-12-29 | Hydro Aluminium Systems Spa | Complesso di profilati metallici per serramenti muniti di squadrette di rinforzo |
WO1993010715A2 (en) | 1991-12-03 | 1993-06-10 | Vesitec Medical, Inc. | Surgical treatment of stress urinary incontinence |
JPH0669494B2 (ja) | 1991-12-04 | 1994-09-07 | 南雄 河野 | 医療用窓付断熱カテーテル |
TW370529B (en) * | 1992-12-17 | 1999-09-21 | Pfizer | Pyrazolopyrimidines |
DK0674641T3 (da) * | 1992-12-17 | 1999-09-27 | Pfizer | Pyrrolopyrimidiner som CRF-antagonister |
JP3398152B2 (ja) | 1993-10-12 | 2003-04-21 | ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー | 1n−アルキル−n−アリールピリミジンアミンおよびその誘導体 |
-
1995
- 1995-05-18 WO PCT/IB1995/000373 patent/WO1995034563A1/en active IP Right Grant
- 1995-05-18 RU RU96123712/04A patent/RU2135498C1/ru not_active IP Right Cessation
- 1995-05-18 AT AT95917436T patent/ATE182332T1/de not_active IP Right Cessation
- 1995-05-18 EP EP95917436A patent/EP0765327B1/en not_active Expired - Lifetime
- 1995-05-18 AU AU23505/95A patent/AU687196B2/en not_active Ceased
- 1995-05-18 DE DE69510940T patent/DE69510940T2/de not_active Expired - Fee Related
- 1995-05-18 NZ NZ284846A patent/NZ284846A/xx unknown
- 1995-05-18 HU HU9603469A patent/HU219911B/hu not_active IP Right Cessation
- 1995-05-18 DK DK95917436T patent/DK0765327T3/da active
- 1995-05-18 JP JP8501868A patent/JP2891544B2/ja not_active Expired - Fee Related
- 1995-05-18 CN CN95193638A patent/CN1056611C/zh not_active Expired - Fee Related
- 1995-05-18 MX MX9606504A patent/MX9606504A/es not_active IP Right Cessation
- 1995-05-18 CA CA002192820A patent/CA2192820C/en not_active Expired - Fee Related
- 1995-05-18 PL PL95317705A patent/PL181895B1/pl not_active IP Right Cessation
- 1995-05-18 CZ CZ19963670A patent/CZ287613B6/cs not_active IP Right Cessation
- 1995-05-18 KR KR1019960707183A patent/KR100235277B1/ko not_active Expired - Fee Related
- 1995-05-18 ES ES95917436T patent/ES2135062T3/es not_active Expired - Lifetime
- 1995-05-25 TW TW084105306A patent/TW432064B/zh active
- 1995-06-05 IL IL11400395A patent/IL114003A/xx not_active IP Right Cessation
- 1995-06-07 BR BR9502707A patent/BR9502707A/pt not_active IP Right Cessation
- 1995-06-07 ZA ZA954679A patent/ZA954679B/xx unknown
- 1995-06-08 CO CO95024908A patent/CO4290424A1/es unknown
- 1995-06-08 PE PE1995270715A patent/PE13396A1/es not_active Application Discontinuation
-
1996
- 1996-12-13 FI FI965022A patent/FI112659B/fi active
- 1996-12-13 NO NO965378A patent/NO307968B1/no not_active IP Right Cessation
-
1999
- 1999-03-11 US US09/266,353 patent/US6248753B1/en not_active Expired - Fee Related
- 1999-09-08 GR GR990402259T patent/GR3031166T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW432064B (en) | Bicyclic compounds and relevant pharmaceutical compositions for the treatment of stress-related diseases | |
US11659074B2 (en) | Information processing terminal | |
CN108769561B (zh) | 视频录制方法及装置 | |
WO2017096509A1 (zh) | 一种显示、处理的方法及相关装置 | |
WO2022083241A1 (zh) | 信息引导方法及装置 | |
CN110932963B (zh) | 多媒体资源分享方法、系统、装置、终端、服务器及介质 | |
CN108965757B (zh) | 视频录制方法、装置、终端及存储介质 | |
WO2014032431A1 (zh) | 终端设备及快速启动程序的方法 | |
CN112230910B (zh) | 嵌入型程序的页面生成方法、装置、设备及存储介质 | |
CN109729372A (zh) | 直播间切换方法、装置、终端、服务器及存储介质 | |
WO2022161267A1 (zh) | 视频录制方法及装置 | |
CN112417180B (zh) | 生成影集视频的方法、装置、设备及介质 | |
CN111966314A (zh) | 图像投屏方法、图像投屏装置、移动终端以及投屏设备 | |
CN105872508A (zh) | 一种基于智能手机的投影仪及呈现多媒体的方法 | |
WO2024067468A1 (zh) | 基于图像识别的交互控制方法、装置及设备 | |
TW200812371A (en) | Interactive document camera and system of the same | |
CN108287900A (zh) | 一种手持拍照设备的搜题方法、系统及手持拍照设备 | |
CN115484391B (zh) | 一种拍摄方法及电子设备 | |
CN114637436A (zh) | 信息分享方法、装置、计算机可读存储介质以及终端 | |
CN103631401A (zh) | 一种便携式交互式投影设备及其投影方法 | |
CN103179366A (zh) | 一种投影应用装置及投影装置结合影像输出装置的系统 | |
WO2022228301A1 (zh) | 文档生成方法、装置和电子设备 | |
CN114584704A (zh) | 拍摄方法、装置和电子设备 | |
CN112242945B (zh) | 电子互动信息的发送方法、装置、设备及可读存储介质 | |
CN202956581U (zh) | 可携式投影机 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent |